LEADER 01660nam  2200373   450 
001 9910688220503321
005 20230624191337.0
024 7 $a10.5772/intechopen.77785
035   $a(CKB)5400000000043901
035   $a(NjHacI)995400000000043901
035   $a(EXLCZ)995400000000043901
100   $a20230624d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvances in Hematologic Malignancies /$fedited by Gamal Abdul Hamid
210  1$aLondon, England :$cIntechOpen,$d2019.
215   $a1 online resource (176 pages)
311   $a1-83962-657-7 
330   $aThe book Advances in Hematologic Malignancies presents new knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic, and genomic changes that have influenced the current outlook toward hematological malignancies. This book provides a unique, practical, and concise guide that is focused on the must-know points of diagnosis, prognosis, therapeutic management, and cutting edge clinical trial opportunities for each hematologic malignancy. Advances in Hematologic Malignancies is designed and organized as an essential reference source for the hematologist, hematologic oncologist, hematopathologist, and trainee.
606   $aOncology
606   $aCancer
615  0$aOncology.
615  0$aCancer.
676   $a616.994
702   $aHamid$b Gamal Abdul
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688220503321
996   $aAdvances in Hematologic Malignancies$92135871
997   $aUNINA